We are happy to announce that the paper of our clinical trial in patients with a Barrett’s Oesophagus is published online in the journal Gut, a leading international journal in gastroenterology and hepatology (2016 impact factor: 16.658) We would like to thank all the co-autors, patients and collaborateurs that made this trial to a great succes. The full
Recently we started a phase II-b multicenter study that aims to further characterize the performance of EMI-137, a fluorescent compound targeting c-Met, for detection of dysplastic colorectal polyps during colonoscopy. In this study, patients with a high suspicion of colorectal cancer (CRC) that are scheduled to undergo a colonoscopy will be enrolled. Study patients will
Wednesday November 29th Elmire Hartmans successfully defended her PhD thesis and subsequently got her PhD degree. Congratulations!
The collaboration with Rudolf Fehrmann has led to a publication in Journal of Nuclear Medicine. We used functional genomic mRNA profiling to identify novel targets for theranostic approaches in pancreatic cancer. The manuscript can be viewed here: https://www.ncbi.nlm.nih.gov/pubmed/29051346 Data driven prioritization and review of targets for molecular based theranostic approaches in pancreatic cancer. Koller M, Hartmans E,